Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 16, 2022; 10(23): 8088-8096
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8088
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8088
Beta receptor blocker therapy for the elderly in the COVID-19 era
Elpidio Santillo, Monica Migale, Geriatric Rehabilitative Department, IRCCS-INRCA, Fermo 63900, Italy
Author contributions: Santillo E performed the majority of the writing, prepared the figure and table, designed the outline, and coordinated the writing of the paper; Migale M performed the data acquisition and initial writing, and provided input in subsequent drafts of the paper; both authors have read and approved the final manuscript.
Conflict-of-interest statement: All authors have no conflicts of interest to declare.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Elpidio Santillo, MD, PhD, Staff Physician, Geriatric Rehabilitative Department, IRCCS-INRCA, C.da Mossa 2, Fermo 63900, Italy. elpisant@tin.it
Received: April 6, 2022
Peer-review started: April 6, 2022
First decision: June 16, 2022
Revised: June 26, 2022
Accepted: July 11, 2022
Article in press: July 11, 2022
Published online: August 16, 2022
Processing time: 116 Days and 17.6 Hours
Peer-review started: April 6, 2022
First decision: June 16, 2022
Revised: June 26, 2022
Accepted: July 11, 2022
Article in press: July 11, 2022
Published online: August 16, 2022
Processing time: 116 Days and 17.6 Hours
Core Tip
Core Tip: This minireview offers an original and innovative summary of recent studies of the usefulness of beta blocker therapy for the elderly in the coronavirus disease 2019 (COVID-19) pandemic. We discuss the pharmacologic benefits of beta blocker therapy for older subjects and report the results of early studies highlighting the favorable effects of beta blockers on elderly patients affected by COVID-19.